Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norberto Perico

Showing results (111-120 of 202) with videos related to

Pageof 21
Sort By:
Therapeutic Drug Monitoring|October 14, 2006
Mycophenolic acid formulation affects cyclosporine pharmacokinetics in stable kidney transplant recipientsDario Cattaneo, Simona Merlini, Sara Baldelli, et al.
Pharmacogenomics|October 11, 2007
C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantationSara Baldelli, Simona Merlini, Norberto Perico, et al.
Clinical Biochemistry|October 24, 2006
Comparison of the Innofluor certican assay with HPLC-UV for the determination of everolimus concentrations in heart transplantationSara Baldelli, Alberto Crippa, Roberta Gabrieli, et al.
Journal of the American Society of Nephrology : JASN|October 7, 2004
Targeted deletion of angiotensin II type 1A receptor does not protect mice from progressive nephropathy of overload proteinuriaAriela Benigni, Daniela Corna, Carla Zoja, et al.
The American Journal of Pathology|June 21, 2011
Intermediate volume on computed tomography imaging defines a fibrotic compartment that predicts glomerular filtration rate decline in autosomal dominant polycystic kidney disease patientsAnna Caroli, Luca Antiga, Sara Conti, et al.
Journal of the American Society of Nephrology : JASN|August 24, 2001
Combined treatment with mycophenolate mofetil and an angiotensin II receptor antagonist fully protects from chronic rejection in a rat model of renal allograftMarina Noris, Nadia Azzollini, Angela Pezzotta, et al.
European Radiology|April 5, 2023
Diffusion magnetic resonance imaging for kidney cyst volume quantification and non-cystic tissue characterisation in ADPKDAnna Caroli, Giulia Villa, Paolo Brambilla, et al.
Plos One|May 21, 2015
Sirtuin3 Dysfunction Is the Key Determinant of Skeletal Muscle Insulin Resistance by Angiotensin IIDaniela Macconi, Luca Perico, Lorena Longaretti, et al.
Kidney International|November 25, 2003
ACE inhibition limits chronic injury of kidney transplant even with treatment started when lesions are establishedMarina Noris, Marilena Mister, Anna Pezzotta, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 23, 2004
Therapeutic drug monitoring of sirolimus: effect of concomitant immunosuppressive therapy and optimization of drug dosingDario Cattaneo, Simona Merlini, Marisa Pellegrino, et al.
Pageof 21

Showing results (111-120 of 202) with videos related to

Sort By:
Pageof 21
Therapeutic Drug Monitoring|October 14, 2006
Mycophenolic acid formulation affects cyclosporine pharmacokinetics in stable kidney transplant recipientsDario Cattaneo, Simona Merlini, Sara Baldelli, et al.
Pharmacogenomics|October 11, 2007
C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantationSara Baldelli, Simona Merlini, Norberto Perico, et al.
Clinical Biochemistry|October 24, 2006
Comparison of the Innofluor certican assay with HPLC-UV for the determination of everolimus concentrations in heart transplantationSara Baldelli, Alberto Crippa, Roberta Gabrieli, et al.
Journal of the American Society of Nephrology : JASN|October 7, 2004
Targeted deletion of angiotensin II type 1A receptor does not protect mice from progressive nephropathy of overload proteinuriaAriela Benigni, Daniela Corna, Carla Zoja, et al.
The American Journal of Pathology|June 21, 2011
Intermediate volume on computed tomography imaging defines a fibrotic compartment that predicts glomerular filtration rate decline in autosomal dominant polycystic kidney disease patientsAnna Caroli, Luca Antiga, Sara Conti, et al.
Journal of the American Society of Nephrology : JASN|August 24, 2001
Combined treatment with mycophenolate mofetil and an angiotensin II receptor antagonist fully protects from chronic rejection in a rat model of renal allograftMarina Noris, Nadia Azzollini, Angela Pezzotta, et al.
European Radiology|April 5, 2023
Diffusion magnetic resonance imaging for kidney cyst volume quantification and non-cystic tissue characterisation in ADPKDAnna Caroli, Giulia Villa, Paolo Brambilla, et al.
Plos One|May 21, 2015
Sirtuin3 Dysfunction Is the Key Determinant of Skeletal Muscle Insulin Resistance by Angiotensin IIDaniela Macconi, Luca Perico, Lorena Longaretti, et al.
Kidney International|November 25, 2003
ACE inhibition limits chronic injury of kidney transplant even with treatment started when lesions are establishedMarina Noris, Marilena Mister, Anna Pezzotta, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 23, 2004
Therapeutic drug monitoring of sirolimus: effect of concomitant immunosuppressive therapy and optimization of drug dosingDario Cattaneo, Simona Merlini, Marisa Pellegrino, et al.
Pageof 21